Cite
HARVARD Citation
Zhang, S. et al. (n.d.). 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, S. et al. (n.d.). 87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience. Immuno-oncology technology. p. . [Online].